Research study Program year 2023 Source: CMS Open Payments

A 12-Week, Multicenter, Active-Treatment Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

ClinicalTrials.gov NCT03594123

Research payments

$717,644

68 payments

Through program year 2023, $717,644 in research payments was reported against A 12-Week, Multicenter, Active-Treatment Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type, across 68 payments, paid by Otsuka Pharmaceutical Development & Commercialization, Inc..

Paid by
Otsuka Pharmaceutical Development & Commercialization, Inc.
ClinicalTrials.gov
NCT03594123

By program year

3 rows
Year Kind Amount Payments
2023 Research $139,710 26
2022 Research $335,872 22
2021 Research $242,062 20

Breakdown

Who paid Research payments · program years 2021–2023
  1. Otsuka Pharmaceutical Development & Commercialization, Inc. $717,644 68 payments
Who received the money Research payments · program years 2021–2023
  1. Shreenath Clinical Service Organisation paid for research $272,328 3 payments
  2. New Life Medical Research INC Organisation paid for research $50,516 2 payments
  3. Project 4 Research INC Organisation paid for research $33,850 2 payments
  4. Relaro Medical Trials Organisation paid for research $31,347 3 payments
  5. Elias Research Associates LLC Organisation paid for research $25,598 7 payments
  6. Mdfirst Research Chandler LLC Organisation paid for research $23,878 3 payments
  7. Innovation Medical Research Center INC Organisation paid for research $22,624 2 payments
  8. Humanity Clinical Research Corp Organisation paid for research $21,197 2 payments
  9. Health Care Family Rehab & Research Center Organisation paid for research $20,565 3 payments
  10. South Florida Research Phase I-IV Organisation paid for research $20,165 2 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record